Real-time prescription drug monitoring program in Australia: We should be ready
Sir—Referring to the replication of Tasmanian real-time prescription drug monitoring program (PMP) in other Australian states, Nielsen and Bruno, in their recent Editorial , raised several key questions that need to be considered. The first question was the range of drugs to be monitored. The proposed PMP will monitor only Schedule-8 controlled drugs which do not cover weaker opioids (e.g. tramadol) and a majority of benzodiazepines.
|Collections||ANU Research Publications|
|Source:||Drug and Alcohol Review|